Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
- Analyst Ratings
Upturn AI SWOT - About
Definitive Healthcare Corp (DH)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
06/30/2025: DH (1-star) has a low Upturn Star Rating. Not recommended to BUY.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
Number of Analysts
14 Analysts rated it
Well-followed company, solid analyst reports, reliable data for confident investing.
1 Year Target Price $4.1
1 Year Target Price $4.1
| 3 | Strong Buy |
| 0 | Buy |
| 9 | Hold |
| 2 | Sell |
| 0 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit -48.1% | Avg. Invested days 21 | Today’s Advisory Consider higher Upturn Star rating |
Upturn Star Rating | Upturn Advisory Performance  2.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 06/30/2025 |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 408.97M USD | Price to earnings Ratio - | 1Y Target Price 4.1 |
Price to earnings Ratio - | 1Y Target Price 4.1 | ||
Volume (30-day avg) 14 | Beta 1.58 | 52 Weeks Range 2.15 - 6.16 | Updated Date 06/30/2025 |
52 Weeks Range 2.15 - 6.16 | Updated Date 06/30/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) -4.41 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Revenue by Geography
Geography revenue - Year on Year
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin -206.05% | Operating Margin (TTM) -11.81% |
Management Effectiveness
Return on Assets (TTM) -0.43% | Return on Equity (TTM) -89.99% |
Valuation
Trailing PE - | Forward PE 18.15 | Enterprise Value 388907650 | Price to Sales(TTM) 1.65 |
Enterprise Value 388907650 | Price to Sales(TTM) 1.65 | ||
Enterprise Value to Revenue 1.57 | Enterprise Value to EBITDA 46.69 | Shares Outstanding 107342000 | Shares Floating 41919160 |
Shares Outstanding 107342000 | Shares Floating 41919160 | ||
Percent Insiders 9.08 | Percent Institutions 96.93 |
Analyst Ratings
Rating 4 | Target Price 4.1 | Buy - | Strong Buy 3 |
Buy - | Strong Buy 3 | ||
Hold 9 | Sell 2 | Strong Sell - | |
Strong Sell - |
Upturn AI SWOT
Definitive Healthcare Corp
Company Overview
History and Background
Definitive Healthcare Corp was founded in 2011. It evolved from providing healthcare data to offering a comprehensive intelligence platform for the healthcare ecosystem, going public in 2021.
Core Business Areas
- Commercial Intelligence: Provides data and analytics on healthcare providers, facilities, and affiliated networks to help clients identify market opportunities and optimize sales and marketing efforts.
- Referral Management: Offers solutions to facilitate and improve patient referral processes between healthcare providers.
- Analytics and Strategy: Helps healthcare organizations and life sciences companies make data-driven decisions through custom analytics and strategic consulting services.
Leadership and Structure
Robert Musslewhite serves as the Chief Executive Officer. The company has a structured organizational framework with dedicated teams for sales, marketing, product development, and customer success, overseen by a board of directors.
Top Products and Market Share
Key Offerings
- Market Data: Data about specialists, and doctors in the healthcare industry.
- Monocl ExpertInsight: A platform providing insights into key opinion leaders and scientific experts in the healthcare field. Competitors include Veeva Systems (VEEV) and IQVIA (IQV).
- Number of Users: Thousands of users across pharmaceutical, biotech, and medical device companies.
- Revenue: Estimated to be a substantial portion of Definitive Healthcare's subscription-based revenue.
- Market Data: Detailed data on healthcare organizations, including affiliations, technology installations, and financial performance.
- Number of Users: Hundreds of healthcare organizations and life sciences companies.
- Passport Analytics Suite: An analytics suite offering comprehensive data and insights on healthcare providers and facilities. Competitors include Clarivate (CLVT) and symplr.
- Revenue: A key component of Definitive Healthcare's recurring revenue stream.
Market Dynamics
Industry Overview
The healthcare data and analytics market is experiencing significant growth driven by the increasing need for data-driven insights in healthcare decision-making.
Positioning
Definitive Healthcare Corp is positioned as a provider of commercial intelligence, sales enablement, and strategic planning solutions to the healthcare industry.
Total Addressable Market (TAM)
Estimated at over $20 billion. Definitive Healthcare Corp. has a substantial opportunity to expand within this TAM.
Upturn SWOT Analysis
Strengths
- Comprehensive healthcare data coverage
- Strong subscription-based revenue model
- Established relationships with healthcare organizations and life sciences companies
- Scalable platform architecture
Weaknesses
- High customer concentration
- Integration risks from acquisitions
- Vulnerability to data breaches
- Reliance on third-party data providers
Opportunities
- Expanding product offerings through acquisitions
- Leveraging AI and machine learning to enhance data insights
- Increasing penetration in international markets
- Partnerships to broaden data reach
Threats
- Intense competition from established players
- Changes in healthcare regulations
- Economic downturn affecting healthcare spending
- Emergence of disruptive technologies
Competitors and Market Share
Key Competitors
- IQVIA (IQV)
- Veeva Systems (VEEV)
- Clarivate (CLVT)
Competitive Landscape
Definitive Healthcare Corp differentiates itself through its focus on commercial intelligence and a comprehensive data platform. It faces competition from larger, more diversified companies.
Major Acquisitions
Tagger Media
- Year: 2022
- Acquisition Price (USD millions): 150
- Strategic Rationale: Acquisition to enhance marketing and sales capabilities within the healthcare space, specifically leveraging influencer marketing data.
Trilliant Health
- Year: 2023
- Acquisition Price (USD millions): 325
- Strategic Rationale: Acquisition to help Definitive Healthcare extend its data and analytics capabilities to hospitals, health systems, and other healthcare players.
Growth Trajectory and Initiatives
Historical Growth: Definitive Healthcare Corp has experienced significant growth since its inception, driven by increasing demand for its data and analytics solutions.
Future Projections: Analyst estimates project continued growth, supported by product innovation and market expansion. Revenue growth is expected to be at 10% for 2024
Recent Initiatives: Recent initiatives include acquisitions to expand product offerings, investments in AI and machine learning, and partnerships to broaden data reach.
Summary
Definitive Healthcare is positioned to continue its grow in the healthcare commercial intelligence sector. Strengths include a subscription model and comprehensive data. Areas of concern are high customer concentration and reliance on third-party data. Future growth hinges on product innovation and market expansion, but threats include intense competition and regulatory changes.
Peer Comparison
Sources and Disclaimers
Data Sources:
- Definitive Healthcare Investor Relations
- Company SEC Filings (10-K, 10-Q)
- Market Research Reports
- Analyst Reports
Disclaimers:
This analysis is based on publicly available information and represents a general assessment. Investors should conduct their own due diligence before making investment decisions. Market Share (%) is approximated.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Definitive Healthcare Corp
Exchange NASDAQ | Headquaters Framingham, MA, United States | ||
IPO Launch date 2021-09-15 | CEO & Director Mr. Kevin D. Coop | ||
Sector Healthcare | Industry Health Information Services | Full time employees 782 | Website https://www.definitivehc.com |
Full time employees 782 | Website https://www.definitivehc.com | ||
Definitive Healthcare Corp., together with its subsidiaries, provides software as a service (SaaS) healthcare commercial intelligence platform in the United States and internationally. Its SaaS platform provides information on healthcare providers and their activities to help its customers from product development to go-to-market planning, and sales and marketing execution. The company's platform consists of various functional areas, such as sales, marketing, clinical research and product development, strategy, talent acquisition, and physician network management. It serves biopharmaceutical and medical device companies, healthcare information technology companies, and healthcare providers; and other diversified companies comprising staffing and commercial real estate firms, financial institutions, and other organizations in the healthcare ecosystem. Definitive Healthcare Corp. was founded in 2011 and is headquartered in Framingham, Massachusetts.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.